CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05027867
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:38.091176+00:00
Published At: 2023-08-16T00:00:00+00:00
Record Updated At: 2023-08-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Small-cell Lung Cancer", "Small Cell Lung Carcinoma", "Small Cell Lung Cancer Extensive Stage", "Small Cell Lung Cancer Recurrent"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-08-16"
protocolSection.identificationModule.nctId: "NCT05027867"
protocolSection.identificationModule.officialTitle: "An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.